Data / Drug companies / Tablet, multilayer, extended release

Companies that list tablet, multilayer, extended release products: 31 companies and 66 products in the FDA NDC directory

The FDA National Drug Code Directory lists 66 products that are tablet, multilayer, extended release products from 31 companies. The ten largest listers hold 59.1% of them, and the newest started marketing on October 15, 2026.

SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.

Companies

31

Products

66

Drugs by generic name

7

Main marketing category

Generic drugs (ANDA)

Companies that list tablet, multilayer, extended release products

Ranked by number of products in commercial distribution.

Drugs most often listed

Updated November 6, 2026. Read from US Food and Drug Administration, National Drug Code Directory (openFDA). CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.